Pharmaceutical and Biomedical Project Management in a Changing Global Environment

This book explores many critical forces at work today in pharmaceutical and medical product development. Applying a structured project management framework enables companies to select and allocate the appropriate people and resources to achieve success. A best practices guide to bringing new pharmaceutical or biomedical innovations to market With stringent requirements for quality and patient safety, developing biomedical products is one of the toughest commercial endeavors a company can undertake. Companies continually strive to accelerate new product introductions by reducing development time. However, the best technologies and product concepts cannot reach patients without effective resource management planning for delivering results. With contributions from experts in the pharmaceutical, medical device, and biotechnology industries, this multidisciplinary guide to project management offers solutions to the problems faced when bringing a highly technical and regulated product to the marketplace. Chapter-by-chapter, the book addresses the following topics: Project leadership in the biomedical industry The role of project management throughout the product lifecycle Clinical trials and project management Project management in drug and device development Managing product risk Building alliances Technology transfer Challenges in an international environment For any life sciences professional facing these daily realities, this indispensable reference is the key to maximizing resources, keeping costs and schedules in check, and transforming an idea into a safe, effective, and successful product. Pharmaceutical and Biomedical Portfolio Management in a Changing Global Environment explores some of the critical forces at work today in the complex endeavour of pharmaceutical and medical product development. Written by experienced professionals, and including real-world approaches and best practice examples, this new title addresses three key areas – small molecules, large molecules, and medical devices - and provides hard-to-find, consolidated information relevant to and needed by pharmaceutical, biotech, and medical device company managers.